Suppr超能文献

翻译:翻译:通过翻译后修饰控制死亡受体配体活性。

Control of death receptor ligand activity by posttranslational modifications.

机构信息

Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.

出版信息

Cell Mol Life Sci. 2010 May;67(10):1631-42. doi: 10.1007/s00018-010-0289-7. Epub 2010 Mar 20.

Abstract

The death receptor ligands are involved in many physiological and pathological processes involving triggering of apoptosis, inflammation, proliferation, and activation. The expression of these molecules is reported to be tightly regulated at the transcriptional level. However, over the last few years, an increasing number of data demonstrated that the control of transcription is only one of the mechanisms that manage the expression of the death receptor ligands. Thus, this review is focused on posttranslational regulation of the three main members of this family, namely FasL, TNF-alpha, and TRAIL. We discuss here the importance of distribution, storage, and degranulation of these molecules, as well as their shedding by proteases on the control of death receptor ligands expression and activity.

摘要

死亡受体配体参与了许多涉及触发细胞凋亡、炎症、增殖和激活的生理和病理过程。据报道,这些分子的表达在转录水平受到严格调控。然而,在过去的几年中,越来越多的研究数据表明,转录的控制只是管理死亡受体配体表达的机制之一。因此,本综述集中讨论了这个家族的三个主要成员(即 FasL、TNF-α和 TRAIL)的翻译后调控。我们在这里讨论了这些分子的分布、储存和脱颗粒以及蛋白酶对其脱落对死亡受体配体表达和活性的控制的重要性。

相似文献

1
Control of death receptor ligand activity by posttranslational modifications.
Cell Mol Life Sci. 2010 May;67(10):1631-42. doi: 10.1007/s00018-010-0289-7. Epub 2010 Mar 20.
2
Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
Pharmacol Ther. 2013 Nov;140(2):186-99. doi: 10.1016/j.pharmthera.2013.06.009. Epub 2013 Jul 8.
3
Sweet modification and regulation of death receptor signalling pathway.
J Biochem. 2021 Sep 7;169(6):643-652. doi: 10.1093/jb/mvab034.
4
Structural studies of death receptors.
Methods Enzymol. 2014;545:201-42. doi: 10.1016/B978-0-12-801430-1.00009-3.
6
Signaling activated by the death receptors of the TNFR family.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Sep;153(3):173-80. doi: 10.5507/bp.2009.029.
7
Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
Biochem Biophys Res Commun. 2015 Jan 2;456(1):7-12. doi: 10.1016/j.bbrc.2014.11.010. Epub 2014 Nov 13.
9
Targeting death receptors to fight cancer: from biological rational to clinical implementation.
Curr Med Chem. 2010;17(25):2713-28. doi: 10.2174/092986710791859342.
10
Engineering death receptor ligands for cancer therapy.
Cancer Lett. 2013 May 28;332(2):163-74. doi: 10.1016/j.canlet.2010.12.019. Epub 2011 Jan 14.

引用本文的文献

1
Protein post-translational modifications in the regulation of cancer hallmarks.
Cancer Gene Ther. 2023 Apr;30(4):529-547. doi: 10.1038/s41417-022-00464-3. Epub 2022 Apr 7.
2
sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.
Int J Mol Sci. 2021 Feb 22;22(4):2177. doi: 10.3390/ijms22042177.
3
HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules.
Med Microbiol Immunol. 2019 Dec;208(6):835-844. doi: 10.1007/s00430-019-00625-6. Epub 2019 Jul 18.
4
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Cell Mol Life Sci. 2016 May;73(10):2017-27. doi: 10.1007/s00018-016-2164-7. Epub 2016 Feb 24.
6
Life in the Fas lane: differential outcomes of Fas signaling.
Cell Mol Life Sci. 2013 Nov;70(21):4085-99. doi: 10.1007/s00018-013-1327-z. Epub 2013 Apr 12.
8
Apoptosis and the airway epithelium.
J Allergy (Cairo). 2011;2011:948406. doi: 10.1155/2011/948406. Epub 2011 Dec 13.
10
Tumor necrosis factor alpha-induced inflammation is increased but apoptosis is inhibited by common food additive carrageenan.
J Biol Chem. 2010 Dec 10;285(50):39511-22. doi: 10.1074/jbc.M110.159681. Epub 2010 Oct 11.

本文引用的文献

2
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
Nature. 2009 Oct 1;461(7264):659-63. doi: 10.1038/nature08402.
3
Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.
J Neurooncol. 2010 Apr;97(2):171-85. doi: 10.1007/s11060-009-0010-6. Epub 2009 Sep 20.
5
Enrichment and analysis of secretory lysosomes from lymphocyte populations.
BMC Immunol. 2009 Jul 29;10:41. doi: 10.1186/1471-2172-10-41.
7
ADAM17: the new face of breast cancer-promoting metalloprotease activity.
Cancer Biol Ther. 2009 Jun;8(11):1055-7. doi: 10.4161/cbt.8.11.8758. Epub 2009 Jun 17.
8
Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Cytokine. 2009 Jun;46(3):309-15. doi: 10.1016/j.cyto.2009.03.002. Epub 2009 Apr 5.
10
Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling.
Biochem J. 2009 Apr 1;419(1):185-92, 2 p following 192. doi: 10.1042/BJ20081212.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验